PLARIT 90mg Tablet

750.00৳ 

  •  Size Guide

    Size Guide

  •  Delivery & Return

    Delivery

    Store delivery FREE

    1-3 working days

    Home or collection point from £35.00 FREE

    On all your orders for home or collection point delivery

    Returns

    Return

    We will accept exchanges and returns of unworn and unwashed garments within 30 days of the date of purchase (14 days during the sales period).

    Returns in store FREE

    Your return will usually be processed within a week to a week and a half. We’ll send you a Return Notification email to notify you once the return has been completed. Please allow 1-3 business days for refunds to be received to the original form of payment once the return has been processed.

  •  Ask a Question
  ... people are viewing this right now

  Share
Guaranteed Safe CheckoutTrust

 

Medicine Overview of Plarit 90mg Tablet

Introduction

Plarit 90 belongs to a group of medicines called antiplatelets or blood thinners. It reduces the formation of harmful blood clots in blood vessels. This helps to prevent a heart attack or stroke in people with heart disease.

Plarit 90 is also used to treat people with a recent heart attack or severe heart-related chest pain (unstable angina), who have undergone stenting of the heart. It helps to prevent serious heart-related problems like having another heart attack, stroke, or formation of blood clots in stents in such people.

Your doctor will also prescribe aspirin, another antiplatelet medicine, along with it. This medicine may be taken with or without food and should be taken regularly at the same time each day. It is important to keep taking this medicine even if you feel well. If you stop taking this medicine, it may increase your chances of having another heart attack or stroke.

The most common side effect seen with this medicine is bleeding. If you cut or injure yourself, it may take longer than usual for the bleeding to stop. Such episodes of bleeding are usually mild and resolve on their own. Some people may develop mild breathlessness after taking this medicine, however, this usually resolves on its own with continued treatment. Let your doctor know if bleeding persists or if the breathlessness worsens or does not go away.

Plarit 90 is not suitable for some people. Do not take it if you are bleeding from anywhere in the body such as a stomach ulcer or bleeding within the brain, or if you have severe liver problems.

 

Uses of Plarit 90
  • Prevention of heart attack and stroke
  • Heart attack
Side effects of Plarit 90
Common
  • Bleeding
  • Breathlessness
How to use Plarit 90
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Plarit 90 may be taken with or without food, but it is better to take it at a fixed time.
How Plarit 90 works
Plarit 90 is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
What if you forget to take Plarit 90?
If you miss a dose of Plarit 90, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Quick Tips
  • For best results, take it at the same time every day.
  • Plarit 90 increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
  • Do not discontinue using the medicine without consulting your doctor as this may increase your chances of having another heart attack or stroke.

     

  • If you are scheduled to undergo a surgery or dental treatment, you may be asked to stop taking Plarit 90 temporarily.
  • You may experience shortness of breath in the initial weeks of therapy. Notify your doctor if it becomes worse or persists for long.
Brief Description
Indication
Prevention of thrombotic events, [cardiovascular death (CV), myocardial infarction (MI) and stroke] in patients with acute coronary syndromes (ACS) [unstable angina, non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI)]; including patients managed with percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG).

 

Administration
May be taken with or without food.
Adult Dose
Oral
Acute coronary syndrome
Adult:
Loading dose (following ACS event): 180 mg PO (two 90 mg tablets)
Maintenance dose (for first year following ACS event): 90 mg PO BID
Maintenance dose (after 1 year with history of MI): 60 mg PO BIDAdminister with aspirin: Initial aspirin loading dose of 325 mg, then maintenance dose of aspirin of 75-100 mg/day; DO NOT exceed aspirin dose of 100 mg/day.

Hepatic ImpairmenttModerate to severe: Contraindicated.

 

Renal Dose
Renal impairment
No dosage adjustment needed
Contraindication
History of Intracranial Hemorrhage: Ticagrelor is not recommended in patients with a history of intracranial hemorrhage (ICH) due to a high risk of recurrent ICH in this population. Active Bleeding: Patients with active pathological bleeding eg, peptic ulcer or intracranial hemorrhage.
Severe Hepatic Impairment: Patients with severe hepatic impairment because of a probable increase in exposure, and it has not been studied in these patients. Severe hepatic impairment increases the risk of bleeding because of reduced synthesis of coagulation proteins.
Hypersensitivity (eg, angioedema) to ticagrelor or to any of the components.

 

Mode of Action
Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.

 

Precaution

Patients w/ increased risk of bleeding (e.g. patients who are likely to undergo surgery or invasive procedures). Patients at risk of bradycardic events; w/ history of asthma or COPD, hyperuricaemia or gouty arthritis. Pregnancy and lactation.

Lactation: Unknown whether distributed in human breast milk; potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or to discontinue drug, taking into account the importance of the drug to the mother

 

Side Effect
>10%
Dyspnea (13.8%),Bleeding1-10%
Headache (6.5%),Cough (4.9%),Dizziness (4.5%),Nausea (4.3%),Atrial fibrillation (4.2%),Hypertension (3.8%),Noncardiac chest pain (3.7%),Diarrhea (3.7%),Back pain (3.6%),Hypotension (3.2%),Fatigue (3.2%),Chest pain (3.1%),Syncope (1.7%)

<1%
Dyspena (0.9%)

Bleeding
Non-CABG related bleeds
Total bleeds (major + minor) (8.7%)
Major bleeds (4.5%)
Fatal/life-threatening (2.1%)
Fatal (0.2%)
Intracranial (fatal/life-threatening) (0.3%)

CABG related bleeds
Total major bleeds (85.8%)
Major bleeds when antiplatelet therapy stopped 5 days before CABG (75%)
Fatal/life-threatening (48.1%)
Fatal (0.9%)

 

Interaction
Aminocaproic acid or tranexamic acid &/or recombinant clotting factor VIIa may augment haemostatis. NSAIDs, oral anticoagulants &/or fibrinolytics, ketoconazole, clarithromycin, nefazodone, ritonavir, atazanavir, rifampin, dexamethasone, phenytoin, carbamazepine, phenobarb, simvastatin >40 mg, digoxin. Increased Cmax & AUC w/ cyclosporine.

 

0.00
0 reviews
5
0
4
0
3
0
2
0
1
0
Be the first to review “PLARIT 90mg Tablet”

Your email address will not be published. Required fields are marked *

This field is required.

This field is required.

This field is required.

Reviews

There are no reviews yet.

Categories
Tags
My Cart
Wishlist
Recently Viewed
Compare Products (0 Products)
Compare Product
Compare Product
Compare Product
Compare Product
Categories

PLARIT 90mg Tablet

750.00৳ 

Request a Call Back

    PLARIT 90mg Tablet

    750.00৳ 

    Ask a Question